Recommendations of the Spanish brachytherapy group (GEB) of Spanish Society of Radiation Oncology (SEOR) and the Spanish Society of Medical Physics (SEFM) for high-dose rate (HDR) non melanoma skin cancer brachytherapy
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Rodriguez, S
- Arenas, M
- Gutierrez, C
- Richart, J
- Santos, M
- Rovirosa, A
Grupos
Abstract
Clinical indications of brachytherapy in non-melanoma skin cancers, description of applicators and dosimetry recommendations are described based on the literature review, clinical practice and experience of Spanish Group of Brachytherapy and Spanish Society of Medical Physics reported in the XIV Annual Consensus Meeting on Non Melanoma Skin Cancer Brachytherapy held in Benidorm, Alicante (Spain) on October 21st, 2016. All the recommendations for which consensus was achieved are highlighted in blue. Regular and small surfaces may be treated with Leipzig, Valencia, flap applicators or electronic brachytherapy (EBT). For irregular surfaces, customized molds or interstitial implants should be employed. The dose is prescribed at a maximum depth of 3-4 mm of the clinical target volume/planning target volume (CTV/PTV) in all cases except in flaps or molds in which 5 mm is appropriate. Interstitial brachytherapy should be used for CTV/PTV > 5 mm. Different total doses and fraction sizes are used with very similar clinical and toxicity results. Hypofractionation is very useful twice or 3 times a week, being comfortable for patients and practical for Radiotherapy Departments. In interstitial brachytherapy 2 fractions twice a day are applied.
Datos de la publicación
- ISSN/ISSNe:
- 1699-048X, 1699-3055
- Tipo:
- Article
- Páginas:
- 431-442
- Factor de Impacto:
- 0,883 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico SPRINGER-VERLAG ITALIA SRL
Citas Recibidas en Web of Science: 16
Documentos
- No hay documentos
Filiaciones
Keywords
- Skin brachytherapy; Technical; Dosimetric aspects; Consensus
Campos de estudio
Proyectos asociados
MEDIDA DEL IMPACTO DE LA RADIOTERAPIA CON INTENCIÓN CURATIVA COMBINADA O NO CON TERAPIA HORMONAL SOBRE LA CALIDAD DE VIDA EN LA PRÁCTICA CLÍNICA EN EL CÁNCER DE PRÓSTATA LOCALIZADO. ESTUDIO VEPIC-ORT.
Investigador Principal: FRANCISCO JAVIER CELADA ÁLVAREZ
ONC-MA-1003 . 2016
PROSTATE CANCER OUTCOMES GLOBAL INITIATIVE TO COMPARE AND REDUCE VARIATION IN LOCALISED PROSTATE CANCER ("PCO-CRV").
Investigador Principal: FRANCISCO JAVIER CELADA ÁLVAREZ
PCO-CRV . 2019
ESTUDIO OBSERVACIONAL PARA DESCRIBIR RETROSPECTIVAMENTE LA EVOLUCIÓN DE LOS PACIENTES CON CÁNCER DE PRÓSTATA A LO LARGO DE LA ENFERMEDAD A TRAVÉS DE LA REUTILIZACIÓN DE LOS REGISTROS ELECTRÓNICOS DE SALUD CON INTELIGENCIA ARTIFICIAL. ESTUDIO OVERVIEW.
Investigador Principal: ANTONIO CONDE MORENO
JAN-CPR-2018-01 . 2018
ESTUDIO EPIDEMIOLÓGICO OBSERVACIONAL PROSPECTIVO DEL MANEJO DEL DOLOR EN PACIENTES ONCOLÓGICOS EN TRATAMIENTO RADIOTERÁPICO.
Investigador Principal: FRANCISCO JOSÉ MARTÍNEZ ARCELUS
GOR-ANA-2012-01
TRATAMIENTO RADIOTERÁPICO EN PACIENTES CON CÁNCER DE PRÓSTATA EN FUNCIÓN DEL NIVEL DE RIESGO CONFORME A LA PRÁCTICA CLÍNICA HABITUAL EN LOS SERVICIOS DE ONCOLOGÍA RADIOTERÁPICA ESPAÑOLES.
Investigador Principal: ERICA COLLADO BALLESTEROS
GIC-RAD-2013-01
ESTUDIO DE BRAQUITERAPIA ELECTRÓNICA PARA CARCINOMA CUTÁNEO BASOCELULAR.
Investigador Principal: JOSÉ PÉREZ CALATAYUD
BCCBRACHY
Cita
Rodriguez S,Arenas M,Gutierrez C,Richart J,Perez J,Celada F,Santos M,Rovirosa A. Recommendations of the Spanish brachytherapy group (GEB) of Spanish Society of Radiation Oncology (SEOR) and the Spanish Society of Medical Physics (SEFM) for high-dose rate (HDR) non melanoma skin cancer brachytherapy. Clin Transl Oncol. 2018. 20. (4):p. 431-442. IF:2,441. (3).